C-10291

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameC-10291
Drug Alias NameC-10291
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsDisorders of Excessive SomnolenceFibromyalgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesConcert Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConcert Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDisorders of Excessive SomnolenceFibromyalgia

Other Information

ATC CodeN/A
Related LinksN/A